drugset / Trial / NCT00903357
The Effectiveness of Montelukast on Atopic Dermatitis in Koreans
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to assess the clinical effectiveness of Montelukast in children (2\~6 years old) with atopic dermatitis and identify the pathophysiologic background of Montelukast on the role of modulating the atopic dermatitis measured by urinary Leukotriene 4 (LTE4) and Eosinophil protein X(EDN).
Timeline
- Start
- 2009-08
- Primary completion
- 2010-08
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 4 mg | — |
| Subject | Montelukast | Other / unclassified | 5 mg | — |